High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia

American Journal of Clinical Pathology

Volumn 132, Issue 4, 2009, Pages 589-596

  M'Hidi, Hasni ^b   Thibult, Marie Laure ^a   Chetaille, Bruno ^b   Rey, Françoise ^a   Bouadallah, Reda ^b   Nicollas, Richard ^f   Olive, Daniel ^a,c,e   Xerri, Luc ^b,c,d  

^a INSERM   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d Cancerology and Immunology Institute of Marseille   (France)

^e Cancerology and Immunology Institute of Marseille ^*

^f TIMONE HOSPITAL   (France)

Author keywords

B and T lymphocyte attenuator; BTLA; Chronic lymphocytic leukemia; Flow cytometry; Herpesvirus entry mediator; HVEM; Immunohistochemistry; Small lymphocytic lymphoma; T follicular helper cells; TFH

Indexed keywords

B LYMPHOCYTE ATTENUATOR PROTEIN; LYMPHOCYTE RECEPTOR; T LYMPHOCYTE ATTENUATOR PROTEIN; UNCLASSIFIED DRUG; BTLA PROTEIN, HUMAN; HERPESVIRUS ENTRY MEDIATOR; IMMUNOGLOBULIN RECEPTOR; TNFRSF14 PROTEIN, HUMAN;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL ACTIVATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FOLLICULAR DENDRITIC CELL; GERMINAL CENTER; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; OVARY FOLLICLE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; DOWN REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MOUSE;

ANIMALS; B-LYMPHOCYTES; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 70349560843     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPPHKGYYGGL39C     Document Type: Article

References (35)

1. Watanabe N, Gavrieli M, Sedy JR, et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol. 2003;4:670-679. (Pubitemid 36874444)
2. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol. 2005;23:515-548.
3. Riley JL, June CH. The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation. Blood. 2005;105:13-21.
4. Murphy KM, Nelson CA, Sedý JR. Balancing co-stimulation and inhibition with BTLA and HVEM. Nat Rev Immunol. 2006;6:671-681. (Pubitemid 44298216)
5. Sedy JR, Gavrieli M, Potter KG, et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol. 2005;6:90-98. (Pubitemid 40136700)
6. Gonzalez LC, Loyet KM, Calemine-Fenaux J, et al. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc Natl Acad Sci U S A. 2005;102:1116-1121. (Pubitemid 40170735)
7. Gavrieli M, Watanabe N, Loftin SK, et al. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. Biochem Biophys Res Commun. 2003;312:1236-1243. (Pubitemid 37490949)
8. Otsuki N, Kamimura Y, Hashiguchi M, et al. Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells. Biochem Biophys Res Commun. 2006;344:1121-1127.
9. Krieg C, Han P, Stone R, et al. Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J Immunol. 2005;175:6420-6427. (Pubitemid 41598882)
10. Wang XF, Chen YJ, Wang Q, et al. Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells. Tissue Antigens. 2007;69:145-153. (Pubitemid 46174869)
11. Tao R, Wang L, Murphy KM, et al. Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells. J Immunol. 2008;180:6649-6655.
12. Wang Y, Subudhi SK, Anders RA, et al. The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J Clin Invest. 2005;115:711-717. (Pubitemid 40322246)
13. Fan Z, Yu P, Wang Y, et al. NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors. Blood. 2006;107:1342-1351. (Pubitemid 43242367)
14. Tao R, Wang L, Han R, et al. Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts. J Immunol. 2005;175:5774-5782. (Pubitemid 41508061)
15. Deppong C, Juehne TI, Hurchla M, et al. Cutting edge: B and T lymphocyte attenuator and programmed death receptor-1 inhibitory receptors are required for termination of acute allergic airway inflammation. J Immunol. 2006;176:3909-3913. (Pubitemid 44264367)
16. Steinberg MW, Turovskaya O, Shaikh RB, et al. A crucial role for HVEM and BTLA in preventing intestinal inflammation. J Exp Med. 2008;205:1463-1476. (Pubitemid 351831500)
17. Peggy H, Olivia DG, Kevin R, et al. An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is an early marker of thymocyte positive selection. J Immunol. 2004;172:5931-5939.
18. Olive D, Raymond J, Dubreuil P, et al. Anti-interleukin 2 receptor monoclonal antibodies. Respective role of epitope mapping and monoclonal antibody-receptor interactions in their antagonist effects on interleukin 2-dependent T cell growth. Eur J Immunol. 1986;16:611-616. (Pubitemid 16074134)
19. Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:189-235. World Health Organization Classification of Tumours.
20. Xerri L, Devilard E, Hassoun J, et al. In vivo expression of the CTLA4 inhibitory receptor in malignant and reactive cells from human lymphomas. J Pathol. 1997;183:182-187. (Pubitemid 27436022)
21. Allen CD, Okada T, Tang HL, et al. Imaging of germinal center selection events during affinity maturation. Science. 2007;315:528-531. (Pubitemid 46175759)
22. Hauser AE, Shlomchik MJ, Haberman AM. In vivo imaging studies shed light on germinal-centre development. Nat Rev Immunol. 2007;7:499-504.
23. Nakayama Y, Stabach P, Maher SE, et al. A limited number of genes are involved in the differentiation of germinal center B cells. J Cell Biochem. 2006;99:1308-1325. (Pubitemid 44778464)
24. Chtanova T, Tangye SG, Newton R, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol. 2004;173:68-78. (Pubitemid 38797327)
25. Haynes NM, Allen CD, Lesley R, et al. Role of CXCR5 and CCR7 in follicular TH cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J Immunol. 2007;179:5099-5108.
26. King C, Tangye SG, Mackay CR. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol. 2008;26:741-766. (Pubitemid 351600391)
27. Dorfman DM, Brown JA, Shahsafaei A, et al. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol. 2006;30:802-810. (Pubitemid 44264969)
28. Xerri L, Chetaille B, Seriari N, et al. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Hum Pathol. 2008;39:1050-1058.
29. Lohning M, Hutloff A, Kallinich T, et al. Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J Exp Med. 2003;197:181-193. (Pubitemid 36152313)
30. Rasheed AU, Rahn HP, Sallusto F, et al. Follicular B helper-T cell activity is confined to CXCR5hiICOShi CD4 T cells and is independent of CD57 expression. Eur J Immunol. 2006;36:1892-1903. (Pubitemid 44089055)
31. Ozaki K, Spolski R, Ettinger R, et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol. 2004;173:5361-5371. (Pubitemid 39392119)
32. Hutloff A, Buchner K, Reiter K, et al. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum. 2004;50:3211-3220. (Pubitemid 39371998)
33. Cai G, Anumanthan A, Brown JA, et al. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol. 2008;9:176-185.
34. Chiorazzi N, Hatzi K, Albesiano E. B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens. Ann N Y Acad Sci. 2005;1062:1-12.
35. Ghia P, Chiorazzi N, Stamatopoulos K. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J Intern Med. 2008;264:549-562.